Hydrodynamic modelling as a first step to assess marine dune dynamics: influence of waves

Hydrodynamic

Expressive fluxes over Amazon floodplain revealed by 2D hydrodynamic modelling

Water fluxes in the Amazon River floodplain affect hydrodynamic and ecological processes from local to global scales, but they remain poorly understood due to difficult accessibility and limited data. We characterized the hydrodynamics of eight floodplain units of the central Amazon River (40000 km2) using the 2D hydraulic model HEC-RAS. High resolution modelling (∼400 m) improved the representation of river and floodplain discharge, water surface elevation (77 cm accuracy) and flood extent (∼80% - high water period, ∼52% - low water period) compared to past modelling studies. Our results show that floodplain flows during floods are very intense with upstream inflow and downstream outflow of the floodplain units. These gross flows are much larger than the net flows, with values of up to 20% of the Amazon River discharge and residence time around 6 days during floods (several months during low water period). Water extent did not show strong interannual variability during floods as the volume stored in the floodplain did, possibly due to topographic constraints. Significant hysteresis in flood extent and volume, and active and storage zones on the floodplain highlight the complexity of floodplain hydrodynamics. Extreme floods strongly impacted the onset and duration of the flood by up to one month and, consequently on duration of high water renewal period with the river. Our characterization is important to assess the effects of extreme floods on riverine communities, understand nutrient and sediment variations in the floodplain, and characterize the export of water, sediment, and carbon flux to the ocean from the world's largest hydrological system

Enrollment, retention, and effective strategies for including disadvantaged populations in controlled trials: A systematic review protocol

Background: Many randomized controlled trials fail to reach their target sample size. When coupled with the omission and underrepresentation of disadvantaged groups in randomized controlled trials, many trials fail to obtain data that accurately represents the true diversity of their target population. Policies and practices have been implemented to increase representation of disadvantaged groups in many randomized controlled trials, with some trials specifically targeting such groups. To our knowledge, no systematic review has quantified the enrollment metrics and effectiveness of inclusion and retention strategies in randomized controlled trials focused on disadvantaged populations specifically. Methods: We will conduct a systematic search across EMBASE, MEDLINE, Web of Science, and CINAHL as well as grey literature, conference proceedings, research monographs, and Google Scholar from inception onwards. We will include randomized controlled trials where at least 50% of enrolled participants are considered to be disadvantaged, as per the RCT authors’ definition and in line with our inclusion criteria. Two independent researchers per article will conduct preliminary title and abstract screening, subsequent full text review, and data extraction for the selected trials, with a third reviewer available to resolve conflicts. We will assess the quality of all included studies using specific criteria regarding data reporting, external validity, and internal validity. We will combine all selected studies and conduct a narrative synthesis to assess enrollment metrics. If there is sufficient homogeneity and sufficient trials comparing recruitment strategies within disadvantaged populations, we will conduct a random effects meta-analysis to evaluate the effectiveness of strategies designed to maximize the inclusion of disadvantaged populations in randomized controlled trials. Discussion: The findings of this systematic review will establish baseline recruitment and enrollment metrics of trials targeting disadvantaged populations to elucidate the scope of the challenge of recruiting such populations. We hope that our findings will promote future research on the distinct barriers that may prevent disadvantaged populations from participating in health intervention research, will encourage more trials exploring effective, tailored recruitment strategies, and will establish a foundation to track future progress in the recruitment of disadvantaged populations. Trial registrations: PROSPERO ID: CRD4202015281

Le FORUM, Vol. 34 No. 2

https://digitalcommons.library.umaine.edu/francoamericain_forum/1026/thumbnail.jp

Effect of Coffee and Cocoa-Based Confectionery Containing Coffee on Markers of DNA Damage and Lipid Peroxidation Products: Results from a Human Intervention Study

The effect of coffee and cocoa on oxidative damage to macromolecules has been investigated in several studies, often with controversial results. This study aimed to investigate the effect of one-month consumption of different doses of coffee or cocoa-based products containing coffee on markers of DNA damage and lipid peroxidation in young healthy volunteers. Twenty-one volunteers were randomly assigned into a three-arm, crossover, randomized trial. Subjects were assigned to consume one of the three following treatments: one cup of espresso coffee/day (1C), three cups of espresso coffee/day (3C), and one cup of espresso coffee plus two cocoa-based products containing coffee (PC) twice per day for 1 month. At the end of each treatment, blood samples were collected for the analysis of endogenous and H(2)O(2)-induced DNA damage and DNA oxidation catabolites, while urines were used for the analysis of oxylipins. On the whole, four DNA catabolites (cyclic guanosine monophosphate (cGMP), 8-OH-2′-deoxy-guanosine, 8-OH-guanine, and 8-NO2-cGMP) were detected in plasma samples following the one-month intervention. No significant modulation of DNA and lipid damage markers was documented among groups, apart from an effect of time for DNA strand breaks and some markers of lipid peroxidation. In conclusion, the consumption of coffee and cocoa-based confectionery containing coffee was apparently not able to affect oxidative stress markers. More studies are encouraged to better explain the findings obtained and to understand the impact of different dosages of these products on specific target groups

Effect of Coffee and Cocoa-Based Confectionery Containing Coffee on Markers of DNA Damage and Lipid Peroxidation Products: Results from a Human Intervention Study

The effect of coffee and cocoa on oxidative damage to macromolecules has been investigated in several studies, often with controversial results. This study aimed to investigate the effect of one-month consumption of different doses of coffee or cocoa-based products containing coffee on markers of DNA damage and lipid peroxidation in young healthy volunteers. Twenty-one volunteers were randomly assigned into a three-arm, crossover, randomized trial. Subjects were assigned to consume one of the three following treatments: one cup of espresso coffee/day (1C), three cups of espresso coffee/day (3C), and one cup of espresso coffee plus two cocoa-based products containing coffee (PC) twice per day for 1 month. At the end of each treatment, blood samples were collected for the analysis of endogenous and H2O2-induced DNA damage and DNA oxidation catabolites, while urines were used for the analysis of oxylipins. On the whole, four DNA catabolites (cyclic guanosine monophosphate (cGMP), 8-OH-2′-deoxy-guanosine, 8-OH-guanine, and 8-NO2-cGMP) were detected in plasma samples following the one-month intervention. No significant modulation of DNA and lipid damage markers was documented among groups, apart from an effect of time for DNA strand breaks and some markers of lipid peroxidation. In conclusion, the consumption of coffee and cocoa-based confectionery containing coffee was apparently not able to affect oxidative stress markers. More studies are encouraged to better explain the findings obtained and to understand the impact of different dosages of these products on specific target groups

Amazon hydrology from space : scientific advances and future challenges

As the largest river basin on Earth, the Amazon is of major importance to the world's climate and water resources. Over the past decades, advances in satellite-based remote sensing (RS) have brought our understanding of its terrestrial water cycle and the associated hydrological processes to a new era. Here, we review major studies and the various techniques using satellite RS in the Amazon. We show how RS played a major role in supporting new research and key findings regarding the Amazon water cycle, and how the region became a laboratory for groundbreaking investigations of new satellite retrievals and analyses. At the basin-scale, the understanding of several hydrological processes was only possible with the advent of RS observations, such as the characterization of "rainfall hotspots" in the Andes-Amazon transition, evapotranspiration rates, and variations of surface waters and groundwater storage. These results strongly contribute to the recent advances of hydrological models and to our new understanding of the Amazon water budget and aquatic environments. In the context of upcoming hydrology-oriented satellite missions, which will offer the opportunity for new synergies and new observations with finer space-time resolution, this review aims to guide future research agenda toward integrated monitoring and understanding of the Amazon water from space. Integrated multidisciplinary studies, fostered by international collaborations, set up future directions to tackle the great challenges the Amazon is currently facing, from climate change to increased anthropogenic pressure

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

From MDPI via Jisc Publications RouterHistory: accepted 2021-08-13, pub-electronic 2021-08-18Publication status: PublishedExtra-pulmonary neuroendocrine carcinomas (EP-NECs) are lethal cancers with limited treatment options. Identification of contributing factors to the observed heterogeneity of clinical outcomes within the EP-NEC family is warranted, to enable identification of effective treatments. A multicentre retrospective study investigated potential differences in “real-world” treatment/survival outcomes between small-cell (SC) versus (vs.) non-SC EP-NECs. One-hundred and seventy patients were included: 77 (45.3%) had SC EP-NECs and 93 (54.7%) had non-SC EP-NECs. Compared to the SC subgroup, the non-SC subgroup had the following features: (1) a lower mean Ki-67 index (69.3% vs. 78.7%; p = 0.002); (2) a lower proportion of cases with a Ki-67 index of ≥55% (73.9% vs. 88.7%; p = 0.025); (3) reduced sensitivity to first-line platinum/etoposide (objective response rate: 31.6% vs. 55.1%, p = 0.015; and disease control rate; 59.7% vs. 79.6%, p = 0.027); (4) worse progression-free survival (PFS) (adjusted-HR = 1.615, p = 0.016) and overall survival (OS) (adjusted-HR = 1.640, p = 0.015) in the advanced setting. Within the advanced EP-NEC cohort, subgroups according to morphological subtype and Ki-67 index (55% vs. ≥55%) had significantly different PFS (adjusted-p = 0.021) and OS (adjusted-p = 0.051), with the non-SC subgroup with a Ki-67 index of 55% and non-SC subgroup with a Ki-67 index of ≥55% showing the best and worst outcomes, respectively. To conclude, the morphological subtype of EP-NEC provides complementary information to the Ki-67 index and may aid identification of patients who could benefit from alternative first-line treatment strategies to platinum/etoposide